This injectable solution is formulated with praziquantel at 56.8 mg per mL, along with benzyl alcohol and chlorobutanol hydrous in a propylene glycol base, producing a clear liquid intended for subcutaneous or intramuscular injection in dogs and cats. The label identifies it for removal of cestodes, including Dipylidium caninum and Taenia pisiformis in both species, Echinococcus granulosus in dogs, and for the removal and control of Echinococcus multilocularis in dogs. Each carton contains a glass vial of the labeled fill volume, with dosing drawn up and administered by or under the direction of a licensed veterinarian based on the animal's body weight. The product has been evaluated in breeding and pregnant dogs and cats without reported adverse effects on reproduction. Strict hygienic handling of feces is advised when a dog is suspected of harboring Echinococcus multilocularis, since eggs can be shed in the stool after treatment. This is a federally restricted prescription animal drug, and its use requires authorization from a licensed veterinarian.